CogState Ltd
ASX:CGS

Watchlist Manager
CogState Ltd Logo
CogState Ltd
ASX:CGS
Watchlist
Price: 0.965 AUD -2.53% Market Closed
Market Cap: 166.7m AUD
Have any thoughts about
CogState Ltd?
Write Note

CogState Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CogState Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
CogState Ltd
ASX:CGS
Cash from Financing Activities
-$3.2m
CAGR 3-Years
-160%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
Cash from Financing Activities
-AU$995.5k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Cash from Financing Activities
-AU$39.8m
CAGR 3-Years
-42%
CAGR 5-Years
-32%
CAGR 10-Years
-35%
Medibio Ltd
ASX:MEB
Cash from Financing Activities
AU$2.5m
CAGR 3-Years
-18%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Cash from Financing Activities
-AU$832k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcidion Group Ltd
ASX:ALC
Cash from Financing Activities
AU$4.3m
CAGR 3-Years
-37%
CAGR 5-Years
168%
CAGR 10-Years
N/A
No Stocks Found

CogState Ltd
Glance View

Market Cap
164.8m AUD
Industry
Health Care

Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.

CGS Intrinsic Value
1.607 AUD
Undervaluation 40%
Intrinsic Value
Price

See Also

What is CogState Ltd's Cash from Financing Activities?
Cash from Financing Activities
-3.2m USD

Based on the financial report for Jun 30, 2024, CogState Ltd's Cash from Financing Activities amounts to -3.2m USD.

What is CogState Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-160%

Over the last year, the Cash from Financing Activities growth was -260%. The average annual Cash from Financing Activities growth rates for CogState Ltd have been -160% over the past three years .

Back to Top